Use of Stem Cells to Treat Left Ventricular Hypertrophy
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2023, Vol 4, Issue 3
Abstract
Left Ventricular Hypertrophy is a multifactorial condition involving genetic and signaling pathways. Current recommendations for treating hypertensive LVH include ACE inhibitors, RAS and CCBs. Despite numerous drug therapies for ventricular hypertrophy, patients often deteriorate and experience a decline in ventricular function ultimately leading to heart failure. For this reason, alternative therapies must be investigated. Stem cells possess the potential to divide at a high capacity, self-renew and differentiate into numerous cardiac cell lineages. Furthermore, stem cells are connected to ventricular remodeling and are vital in maintaining the homeostasis of the heart. Further examination of the role of stem cells in LVH could result in the development of targeted therapeutic interventions for prevention or reversal of the phenomenon.
Authors and Affiliations
Hetvi Solanki1, Vincent S Gallicchio1*
Keywords
Related Articles
- EP ID EP721418
- DOI https://doi.org/10.46889/JRMBR.2023.4301
- Views 42
- Downloads 0
Expression of Neuron Specific Neuronal Nuclei Protein (NeuNNP) by AAV2 Shows Diagnosis Ability in Spinal Cord Injury Using Neural Stem Cells
Fibroblast Growth Factor (FGF) shows promising therapy for Spinal Cord Injury (SCI). Neural stem transplantation has been on the role implementing tactics to repair SCI. Considering the hostile hypoxia condition in SCI...
Neutrophils and Neovascularization
Neovascularization (NV) via growth of collateral arteries (arteriogenesis) and capillaries, arterioles and venules (angiogenesis) becomes impaired as ischemia from vascular disease progresses [1-3]. Our hypothesis is tha...
Longitudinal Assessment of FEV1 Change Following Autologous Cellular Therapy
Objective: Current pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet none can alter the natural progression of lung function decli...
Donor Selection is a Critical Component Using Naïve Endogenous Adult Stem Cells for the Treatment of Chronic Diseases and Traumatic Injuries
Naïve adult endogenous stem cell transplants have been used as a substitute for embryonic stem cells and/or induced pluripotent stem cells for treating individuals with autoimmune, cardiovascular, neurological, orthope...
Management of Resistant Endometrium in Cases of Recurrent Implantation Failure Using Endometrial Mesenchymal Stem Cells as an Innovative Regenerative Therapy-A Short Communication
Currently the most accepted definition of Recurrent Implantation Failure (RIF) ,is the absence of achieving clinical pregnancy following transfer of 3 or more good quality embryos in women under 35 years age as well as...